Literature DB >> 2279492

A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine.

A Piepsz1, K Hahn, I Roca, G Ciofetta, G Toth, I Gordon, J Kolinska, J Gwidlet.   

Abstract

There is no standard schedule for the amounts of radiopharmaceutical administered to children at present. Various alternative methods are currently in practice, all with some support from the literature. Optimization of the amount of radiopharmaceutical to be administered is discussed in relation to the radiation burden of such an examination. The Paediatric Task Group of the European Association of Nuclear Medicine has investigated the current situation and now suggests a method for standardization of administered amounts of radiopharmaceutical in paediatrics. The fraction of the adult amount of radiopharmaceutical to be administered should be calculated from the child's body weight according to the accompanying table. In small infants, the minimum amount of a radiopharmaceutical is discussed and suggested amounts to be administered are presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2279492     DOI: 10.1007/bf00811439

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  1 in total

1.  The risk of thyroid cancers following irradiation.

Authors:  G W Dolphin
Journal:  Health Phys       Date:  1968-09       Impact factor: 1.316

  1 in total
  38 in total

1.  Guidelines for radioiodinated MIBG scintigraphy in children.

Authors:  Pierre Olivier; Paula Colarinha; Jure Fettich; Sibylle Fischer; Jörgen Frökier; Francesco Giammarile; Isky Gordon; Klaus Hahn; Levent Kabasakal; Mike Mann; Mercedes Mitjavila; Amy Piepsz; Ute Porn; Rune Sixt; Jeannette van Velzen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-03-26       Impact factor: 9.236

2.  Bone scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Morteímans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

3.  131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.

Authors:  Emilio Bombardieri; Cumali Aktolun; Richard P Baum; Angelika Bishof-Delaloye; John Buscombe; Jean François Chatal; Lorenzo Maffioli; Roy Moncayo; Luc Mortelmans; Sven N Reske
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-12       Impact factor: 9.236

4.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

5.  Acute phase 99mTc-dimercaptosuccinic acid scan in infants with first episode of febrile urinary tract infection.

Authors:  Nikoleta Printza; Evagelia Farmaki; Kalliopi Piretzi; George Arsos; Konstantinos Kollios; Fotios Papachristou
Journal:  World J Pediatr       Date:  2012-01-27       Impact factor: 2.764

6.  Optimised tracer-dependent dosage cards to obtain weight-independent effective doses.

Authors:  F Jacobs; H Thierens; A Piepsz; K Bacher; C Van de Wiele; H Ham; R A Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-24       Impact factor: 9.236

7.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

8.  Is PET/CT necessary in paediatric oncology? For.

Authors:  Christiane Franzius; Kai Uwe Juergens; Otmar Schober
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

9.  Bilirubin levels predict renal cortical changes in jaundiced neonates with urinary tract infection.

Authors:  Ioannis Xinias; Vasiliki Demertzidou; Antigoni Mavroudi; Konstantinos Kollios; Panagiotis Kardaras; Fotis Papachristou; Georgios Arsos; Ioannis Tsiouris
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

10.  At what level of unilateral renal impairment does contralateral functional compensation occur?

Authors:  Amy Piepsz; Alain Prigent; Michèle Hall; Khalid Ismaili; Frank Collier; Hamphrey Ham
Journal:  Pediatr Nephrol       Date:  2005-08-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.